Skip to main content
TipRanks
Go Ultimate75% OFF

Delcath Systems reports Q2 EPS (58c), consensus (60c)

Reports Q2 revenue $0.5M, consensus $740K. “As we approach the August 14 PDUFA date, the Company has been preparing for the commercialization of HEPZATO KIT, if approved,” said Gerard Michel, CEO. “As part of this preparation, we continue to add experienced personnel across the key functional areas involved in commercialization.”

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on DCTH:

Disclaimer & DisclosureReport an Issue

Add as preferred source